Pain Management

Latest News

Incorporating Discussions of Cannabis Use Into Oncology Care Visits

Incorporating Discussions of Cannabis Use Into Oncology Care Visits

By Laura Joszt, MA

September 15th 2024

The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of cannabis into treatment plans for patients with cancer, explained Marie Parish, PharmD, BCOP, of Mayo Clinic.

Marie Parish, PharmD, BCOP, screenshot

Using Cannabis as a Bridge for Symptom Management in Cancer

By Laura Joszt, MA

August 22nd 2024

Discoveries on Temperature and Touch Win Nobel in Medicine

Discoveries on Temperature and Touch Win Nobel in Medicine

By Mary Caffrey

October 4th 2021

The Top 5 Most-Read Pain Management Stories of 2020

The Top 5 Most-Read Pain Management Stories of 2020

December 30th 2020

How Patients Think About Pain May Impact Activity Levels, Study Says

How Patients Think About Pain May Impact Activity Levels, Study Says

December 22nd 2020

More News

April 21st 2015

The Role of Palliative Care in Accountable Care Organizations

Amy S. Kelley, MD, MSHS Diane E. Meier, MD

April 14th 2015

Palliative Care Integrates Value in Cancer Care

Joseph Alvarnas, MD

April 14th 2015

A Need for More, Better, and Earlier Conversations With Cancer Patients About Goals of Care

Rachelle Bernacki, MD, MS Ziad Obermeyer, MD, MPhil

February 9th 2015

Only Some Chronic Diseases Benefit from Disease Management Program

Laura Joszt, MA

A disease management program at the University of Minnesota revealed only some targeted chronic diseases benefitted from the program while others were unaffected.

Mindfulness-Based Techniques Aim to Help Patients Reduce Stress, Manage Pain

September 22nd 2014

Mindfulness-Based Techniques Aim to Help Patients Reduce Stress, Manage Pain

Steven D. Hickman, PsyD, associate clinical professor at the University of California, San Diego, invited a roomful of conference attendees to put down the notes, close their eyes, set an intention, and breathe, gaining an "awareness of the breath." His session, "Mindfulness-Based Stress Reduction for Patients with Chronic or Life-Threatening Illness," highlighted techniques based on 2000-year-old Eastern philosophy that can help patients learn to respond to pain, not react to it.

August 12th 2014

Affordable Care Act Projected to Drive Up Prescription Drug Spending in Coming Years

Specialty drugs expected to account for 40% of total prescription spending by 2016, according to Catamaran Corporation.

July 30th 2014

In Medicare, Connecting Medical and Drug Coverage Results in Richer Benefits, AJMC Study Finds

A study just published in The American Journal of Managed Care examined how benefit design differences affected seniors who received prescription coverage through Medicare Advantage compared with a stand-alone Medicare drug plan. The review showed that integrating drug coverage with medical care resulted in fewer barriers to name-brand drugs, with lower copayments.

July 22nd 2014

HHS Reissues Dsputed 340B Policy on Orphan-Drug Discounts

HHS issued an interpretive rule that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.

July 21st 2014

CMS Announces Changes to Medicare Hospice Drug Rule

Katie Sullivan, MA

Changes to a hospice drug rule will reduce the types of medications that require prior authorization. Previous rules prohibited Medicare hospice patients from filling their Part D medications until they had confirmed that hospice providers did not cover them first.

June 24th 2014

Drug Discount Program Has Drugmakers Crying Foul

This spring as the feds have been drawing up new rules for the program, a pitched battle has broken out between hospitals and drug manufacturers who say the program, known as 340B, is now bloated and badly regulated.

June 19th 2014

The Value of Specialty Pharmaceuticals - A Systematic Review

Martin Zalesak, MD, PhD Joyce S. Greenbaum, BA Joshua T. Cohen, PhD Fotios Kokkotos, PhD Adam Lustig, MS Peter J. Neumann, ScD Daryl Pritchard, PhD Jeffrey Stewart, BA Robert W. Dubois, MD

This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.

June 18th 2014

HHS Will Enforce Disputed Rule Limiting Orphan Exclusion from 340B Drug Discounts

HHS is moving forward with its plan to allow certain hospitals to receive discounts on orphan drugs when they are used for non-orphan conditions despite a court ruling that said the agency did not have the authority to do so.

June 18th 2014

Insurer Begins Huge Palliative Care Program

"Person-centered care" is the buzz phrase floating around the health care industry, and a Pacific Northwest-based giant insurer thinks it has hit the mark with a new palliative care program coming this summer.

June 12th 2014

How Hospital Palliative Care Programs Drive Value

Americans live in one of the most medically advanced societies in human history. But sometimes, there is no cure for what ails us.

June 11th 2014

Evidence of Rise in Medicare Beneficiaries on Pain, Anti-Anxiety Meds

Katie Sullivan, MA

An analysis examining Medicare data found that the number of elderly beneficiaries receiving narcotic painkillers and anti-anxiety medications drastically increased from 2007 to 2012.

May 8th 2014

Castellani: Health Law's Cost-Sharing Could Limit Patient Access To Prescription Drugs

Enrollees in some of the health law's most popular plans will face high cost-sharing requirements that the pharmaceutical industry says could keep patients from getting the drugs they need.

April 29th 2014

Sativex Receives Fast Track Status for Advanced Cancer Pain

Sativex,a cannabinoid developed together by GW Pharmaceuticals and Otsuka, receives FDA's Fast Track status for advanced cancer pain.

April 29th 2014

Drug Monitoring Information Improves Regimen Adherence, Researchers Say

Most people want to take medications as prescribed, even if they sometimes need a little help remembering. For them, an automated system that monitors drug taking and provides feedback after the fact may be more useful than one that nags people when it is time to take a pill, researchers at Carnegie Mellon University say.

April 21st 2014

How Does Drug Coverage Vary by Insurance Type? Analysis of Drug Formularies in the United States

Stephane A. Regnier, PhD, MBA

The proportion of available on-patent drugs covered in low copay tiers varied by insurance type, with the lowest proportion being in Medicare plans.

April 21st 2014

Physician Behavior Impact When Revenue Shifted From Drugs to Services

Bruce Feinberg, DO Scott Milligan, PhD Tim Olson, MBA Winston Wong, PharmD Daniel Winn, MD Ram Trehan, MD Jeffrey Scott, MD

Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.

April 16th 2014

Pharmacists Call for Delay on New Medicaid Generic Reimbursement Rates

Pharmacists and drug manufacturers are pushing the CMS for a one-year transition period before states attempt to implement a new formula mandated under the Patient Protection and Affordable Care Act that will significantly trim Medicaid reimbursement rates for generic drugs.

Christine Strahl, PharmD, MBA, BCPS, Discusses Channels and Methods for Specialty Pharmacy Distribution

April 15th 2014

Christine Strahl, PharmD, MBA, BCPS, Discusses Channels and Methods for Specialty Pharmacy Distribution

Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.

April 11th 2014

High Drug Prices Skewing Payouts to Some Physicians

Ophthalmologists are among Medicare's highest paid specialists-a finding already drawing scrutiny from policymakers and watchdogs worried about waste and overuse.

March 24th 2014

Rethinking Spine Care

Some health systems are moving beyond surgery in serving back pain patients.

March 11th 2014

Killing Pain: Benzo 'Boost' Can Be Deadly

Prescription records show that as use of opioids like OxyContin and Vicodin soared in the 2000s, so did the use of "benzos" such as Xanax, Klonopin, and Ativan, as opioid users discovered tranquilizers could enhance "the high."

March 6th 2014

FDA Budget Increase Not Enough, Advocates Say

The Food and Drug Administration will get a 1% funding increase from President Barack Obama's proposed fiscal 2015 budget, a level some say is not enough to cover the agency's new responsibilities and the increasingly global nature of the products it regulates.

February 27th 2014

Killing Pain: Fewer Opioid Scripts

Doctors and other health providers wrote about 11 million fewer prescriptions for narcotic painkillers in 2013 than in 2012, but some experts expected a bigger drop-off given the brighter spotlight on the nation's opioid epidemic.

February 26th 2014

Managed Markets Summit Highlights Part 1

Session highlights from the Managed Markets Summit in Orlando, FL, February 25-27.

How Clinical Evidence Drives Formulary Decision-Making

February 25th 2014

How Clinical Evidence Drives Formulary Decision-Making

Laurie Wesolowicz, PharmD, director, pharmacy services clinical, Blue Cross Blue Shield of Michigan (BCBSM), says that clinical evidence and other factors can drive formulary decision-making. Evidence can influence the value and coverage recommendations for drugs covered under the pharmacy (formulary) and medical benefits.

February 20th 2014

The Impact of Patient Assistance Programs and the 340B Drug Pricing Program on Medication Cost

Yelba M. Castellon, MD Shahrzad Bazargan-Hejazi, PhD Miles Masatsugu, MD Roberto Contreras, MD

Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.

...

4 5 6 7 8 9 10 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions